Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Toll-like receptor 9 (mouse) polyclonal antibody

ALX-210-637-C200 200 µg 297.00 USD
Do you need bulk/larger quantities?

Product Specification

Alternative Name:TLR9, CD289
Immunogen:Synthetic peptide corresponding to aa 204-224 (L204SLKYNNLTKVPRQLPPSLEY224C) of the N-terminal domain of mouse TLR9 (Toll-like receptor 9).
UniProt ID:Q9EQU3
Species reactivity:Human, Mouse
Applications:ICC, IHC (PS), WB
Recommended Dilutions/Conditions:Immunocytochemistry (acetone fixed cells, >1:400)
Immunohistochemistry (paraffin sections, >1:250)
Western Blot (>1:1,000)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
Purity Detail:Epitope-affinity purified IgG.
Formulation:Liquid. In PBS containing 1mg/ml BSA and 0.1% sodium azide.
Handling:For maximum product recovery after thawing, centrifuge the vial before opening the cap. Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20°C.
Shipping:Shipped on Blue Ice
Long Term Storage:-20°C
210-637 human
Figure 1: Immunohistochemistry of human TLR9 on paraffin section of human tonsil using PAb to Toll-like Receptor 9 (Prod. No. ALX-210-637).
210-637 mouse
Figure 2: Immunohistochemistry of mouse TLR9 on paraffin section of mouse thymus using PAb to Toll-like Receptor 9 (Prod. No. ALX-210-637).
Please mouse over
210-637 human 210-637 mouse

Product Toolbox


Certificate of Analysis


By target:
By biological activity:
TLR Polyclonal antibody
TLR9 Polyclonal antibody
By catalog section:


Technical Service
Customer Service

Related Literature

Product Flyers
Antiviral Signaling
Antiviral Signaling
Download as PDF

Product Flyers
Key TLR Ligands and their Receptors
Key TLR Ligands and their Receptors
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2018 Enzo Life Sciences, Inc.,